Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -98.63x is 56% below its 5-year average of -63.05x, near the low end of its 5-year range (-100.78x–-28.38x).
As of the fiscal period ended Monday, June 30, 2025.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2025 (2025-06-30): -98.63x.
INTEREST COVERAGE RATIO
-98.63x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-63.05x
INTEREST COVERAGE RATIO AVG 10Y
-40.91x
INTEREST COVERAGE RATIO AVG 15Y
-32.01x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-56.44%
CURRENT VS 10Y AVG
-141.09%
CURRENT VS 15Y AVG
-208.08%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-1431.50%
vs the sector median at left
InspireMD, Inc.
Market Cap
$24.60M
Interest Coverage Ratio
-98.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-63.05x
Market Cap
$24.44M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.13M
Interest Coverage Ratio
-5.24x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.22M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
Market Cap
$23.38M
Interest Coverage Ratio
-526.75x
TTM Avg
32.47x
3Y Avg
71.81x
5Y Avg
71.81x
Market Cap
$23.06M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.25M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$27.03M
Interest Coverage Ratio
-133.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $24.60M | -98.63x | N/A | N/A | -63.05x |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $24.13M | -5.24x | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -17.20x | 55.75x | 55.75x | 55.75x |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.38M | -526.75x | 32.47x | 71.81x | 71.81x |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.68M | N/A | N/A | N/A | N/A |
| Modular Medical, Inc. (MODD)vs › | $22.25M | N/A | N/A | N/A | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | -133.63x | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 4.39x | 4.39x | 4.39x | 4.39x |
Interest Coverage
-98.6x
Debt/Equity
0.06
Current Ratio
3.80
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-06-30 | -98.63x |
| 2021-12-31 | -32.49x |
| 2021-09-30 | -100.78x |
| 2021-06-30 | -51.34x |
| 2020-12-31 | -28.38x |
| 2020-09-30 | -57.76x |
| 2020-06-30 | -71.94x |
| 2019-12-31 | -92.81x |
| 2019-09-30 | -27.36x |
| 2019-06-30 | -94.91x |
| 2019-03-31 | -40.65x |
| 2018-12-31 | -18.54x |
| 2018-09-30 | -61.84x |
| 2018-03-31 | -4.48x |
| 2017-12-31 | -60.38x |
| 2017-09-30 | -2085.00x |
| 2017-03-31 | -20.20x |
| 2016-12-31 | -9.72x |
| 2016-09-30 | -8.92x |
| 2016-06-30 | -9.39x |
| 2016-03-31 | -11.34x |
| 2015-12-31 | -12.20x |
| 2015-09-30 | -13.87x |
| 2015-06-30 | -12.99x |
| 2015-03-31 | -16.25x |
| 2014-12-31 | -13.31x |
| 2014-09-30 | -17.95x |
| 2014-06-30 | -20.15x |
| 2014-03-31 | -15.72x |
| 2013-09-30 | -50.45x |
| 2013-03-31 | -1.08x |
| 2012-12-31 | -4.04x |
| 2012-09-30 | -0.78x |
| 2012-06-30 | -36.32x |
| 2012-03-31 | -284.18x |
| 2011-12-31 | -4.50x |
| 2010-09-30 | 1.00x |
| 2009-09-30 | 1.00x |
